In sunitinib resistant tumor cells, miR-663 targets FRAS1 (Fraser Extracellular Matrix Complex Subunit 1) and MDGA1 (MAM Domain Containing Glycosylphosphatidylinositol Anchor 1) transcripts. The gene discussed is FRAS1; the disease is neoplasm.